Publication | Closed Access
The safety of gadolinium in patients with stage 3 and 4 renal failure
156
Citations
11
References
2005
Year
An ARF can occur after gadolinium-based contrast agents in patients with moderate to severe chronic renal failure. Risk factors for ARF after gadolinium toxicity include diabetic nephropathy and low GFR.
| Year | Citations | |
|---|---|---|
Page 1
Page 1